BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20950331)

  • 21. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies.
    Mühlemann K; Wenger C; Zenhäusern R; Täuber MG
    Leukemia; 2005 Apr; 19(4):545-50. PubMed ID: 15729382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Invasive pulmonary aspergillosis in AIDS].
    Darras-Joly C; Lucet JC; Laissy JP; Chochillon C; Casalino E; Joly V; Matheron S; Bouvet E
    Pathol Biol (Paris); 1998 Jun; 46(6):416-7. PubMed ID: 9769872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
    Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
    Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002).
    Fourneret-Vivier A; Lebeau B; Mallaret MR; Brenier-Pinchart MP; Brion JP; Pinel C; Garban F; Pison C; Hamidfar R; Plantaz D; Pelloux H; Grillot R
    J Hosp Infect; 2006 Jan; 62(1):22-8. PubMed ID: 16257084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of a multidisciplinary team for preventing hospital-acquired invasive aspergillosis: five years' experience].
    Etancelin P; Silly S; Merle V; Bonmarchand G; Richard JC; Vannier JP; Nouvellon M
    Pathol Biol (Paris); 2009 Feb; 57(1):71-5. PubMed ID: 19157722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective assessment of secondary prophylaxis for invasive aspergillosis in neutropenic hematology patients and identification of risk factors for relapse of fungal disease.
    Kikuchi M; Nakasone H; Mitani K; Gotoh M; Kobayashi A; Kurita N; Saito T; Sato K; Kanda Y;
    Scand J Infect Dis; 2013 Jul; 45(7):531-6. PubMed ID: 23565772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
    Babor F; Schuster F; Mackenzie C; Meisel R; Schaper J; Sabir H; Siepermann M; Wessalowski R; Janßen G; Borkhardt A; Laws HJ
    Klin Padiatr; 2012 Apr; 224(3):160-5. PubMed ID: 22504775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
    Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive aspergillosis in developing countries.
    Chakrabarti A; Chatterjee SS; Das A; Shivaprakash MR
    Med Mycol; 2011 Apr; 49 Suppl 1():S35-47. PubMed ID: 20718613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
    Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
    Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Emergency lung resections for invasive aspergillosis in neutropenic patients].
    Bernard A; Loire J; Caillot D; Casasnovas O; Couailler JF; Guy H; Favre JP
    Ann Chir; 1995; 49(9):849-53. PubMed ID: 8554284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.
    Vehreschild JJ; Bröckelmann PJ; Bangard C; Verheyen J; Vehreschild MJ; Michels G; Wisplinghoff H; Cornely OA
    Epidemiol Infect; 2012 Oct; 140(10):1848-52. PubMed ID: 22152763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy].
    Rácil Z; Mayer J; Kocmanová I; Wagnerová B; Winterová J; Folber F; Lengerová M; Moulis M; Zácková D; Smardová L; Janíková A; Navrátil M; Dvoráková D; Vorlícek J
    Vnitr Lek; 2008 Feb; 54(2):157-68. PubMed ID: 23687707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients.
    Hori A; Kami M; Kishi Y; Machida U; Matsumura T; Kashima T
    J Hosp Infect; 2002 Mar; 50(3):175-82. PubMed ID: 11886192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.